Tag: USPTO
-
Google: No Open-Source Patent Suits, Microsoft Lists Patents
Information technology giants Google and Microsoft each spelled out new policies yesterday they claim will increase the transparency of their intellectual property practices. Google vowed it would not take legal action against developers of open-source software on some of its patents, and Microsoft published an online tool listing all of the company’s patents. Google’s vow…
-
Patent Granted for Nanotech-Enhanced Biodegradable Polymers
Cereplast Inc., a developer of bio-based plastics in El Segundo, California, received a patent for its process of making biodegradable polymers enhanced with mineral nanoparticles. The U.S. Patent and Trademark Office issued patent number 8,389,614 to Cereplast’s CEO Frederick Scheer and research executive William Kelly, and assigned the patent to Cereplast Inc. on 5 March…
-
Patent Awarded for Lipid Treatments on Lung Infections
A researcher at National Jewish Health, a medical center in Denver, received a patent for methods using naturally occuring lipids to treat infections and inflammation in the lungs. U.S. patent number 8,367,643 was awarded last month to professor of medicine Dennis Voelker and assigned to National Jewish Health. Lipids are oil or fat molecules that…
-
Patent Issued for Drug Technology with Prostate Treatment
Medifocus Inc. in Columbia, Maryland received a patent for a technique of delivering heat-sensitive drugs with its treatment for enlarged prostate. U.S. patent 8,374,702 was awarded to Medifocus chief operating officer John Mon and MIT engineer Alan Fenn on 12 February and assigned to Medifocus. The patent covers a technology for delivering drugs targeted to…
-
FDA Approves Electronic Artificial Retina Implant Device
The U.S. Food and Drug Administration approved the first implant device to restore some visual perception for adults with retinitis pigmentosa, a genetic disease that damages the retina. The Argus II Retinal Prosthesis System is made by Second Sight Medical Products Inc. in Sylmar, California. Retinitis pigmentosa is an eye disease caused by genetic defects…
-
Company, University to Develop 3D Models for Cancer Research
Organovo Holdings Inc. in San Diego, with Oregon Health and Science University in Portland, will develop three dimensional human tissue models to replicate cancer disease for lab testing of potential therapies. The partnership, for which financial terms were not disclosed, will apply Organovo’s 3D printing technology that builds tissue models for testing cancer treatments more…
-
U.S. Patent Issued for Anti-Super Bug Disinfectant
Quick-Med Technologies Inc. in Gainesville, Florida received a patent for its antimicrobial disinfectant technology designed to combat drug-resistant bacteria in medical applications. Patent number 8,343,523 was awarded yesterday by the U.S. Patent and Trademark Office to three inventors, including William Toreki, Quick-Med’s vice- president for research and development. The patent covers the composition and methods…
-
University Develops, Patents New Coke Fuel Process
Researchers at Purdue University’s Calumet campus in Hammond, Indiana created a new less-expensive process for producing coke, a derivative of coal used in the making of steel, and received a U.S. patent for their discovery. Patent number 8,287,696 was awarded by the U.S. Patent and Trademark Office in October to Purdue-Calumet physics professor Robert Kramer…
-
University, Company Share Ion Detection Technology Patent
University of Texas at Arlington and Dionex Corporation in Sunnyvale, California recently received a patent for a new process that detects the charge of ions in a solution, and can enable more sensitive testing for compounds in water, food, and chemicals. Patent 8,293,099 from the U.S. Patent and Trademark Office was awarded in late October…
-
Synthetic Sugars Developer Lands $3.5M Venture Financing
Proterro Inc. in Ewing, New Jersey, a developer of synthetic sucrose for biofuels and chemicals, secured $3.5 million in new venture financing. The company also says the U.S. Patent and Trademark Office (USPTO) issued a notice of allowance for the genetically engineered bacteria used in its production process. The company combines genetic engineering with chemical…